Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 91

1.

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients.

Myklebust MP, Fluge Ø, Immervoll H, Skarstein A, Balteskard L, Bruland O, Dahl O.

Br J Cancer. 2012 Feb 14;106(4):756-62. doi: 10.1038/bjc.2011.548.

PMID:
22333708
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Prognostic role of p53 protein expression in epidermoid carcinoma of the anal canal.

Wong CS, Tsao MS, Sharma V, Chapman WB, Pintilie M, Cummings BJ.

Int J Radiat Oncol Biol Phys. 1999 Sep 1;45(2):309-14.

PMID:
10487550
[PubMed - indexed for MEDLINE]
3.

Overexpression of p53 protein and outcome of patients treated with chemoradiation for carcinoma of the anal canal: a report of randomized trial RTOG 87-04. Radiation Therapy Oncology Group.

Bonin SR, Pajak TF, Russell AH, Coia LR, Paris KJ, Flam MS, Sauter ER.

Cancer. 1999 Mar 15;85(6):1226-33.

PMID:
10189126
[PubMed - indexed for MEDLINE]
4.

Tumor site predicts outcome after radiochemotherapy in squamous-cell carcinoma of the anal region: long-term results of 101 patients.

Grabenbauer GG, Kessler H, Matzel KE, Sauer R, Hohenberger W, Schneider IH.

Dis Colon Rectum. 2005 Sep;48(9):1742-51.

PMID:
15991058
[PubMed - indexed for MEDLINE]
5.

[Epidermoid carcinomas of anal canal treated with radiation therapy and concomitant chemotherapy (5-fluorouracil and cisplatin)].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Hannoun L, Houry S, Huguet F, Pène F, Parc R, Schlienger M.

Cancer Radiother. 2006 Dec;10(8):572-82. Epub 2006 Nov 15. French.

PMID:
17110148
[PubMed - indexed for MEDLINE]
6.

Epidermoid anal cancer: treatment by radiation alone or by radiation and 5-fluorouracil with and without mitomycin C.

Cummings BJ, Keane TJ, O'Sullivan B, Wong CS, Catton CN.

Int J Radiat Oncol Biol Phys. 1991 Oct;21(5):1115-25.

PMID:
1938508
[PubMed - indexed for MEDLINE]
7.

Cisplatin-based combined modality therapy for anal carcinoma: a wider therapeutic index.

Hung A, Crane C, Delclos M, Ballo M, Ajani J, Lin E, Feig B, Skibber J, Janjan N.

Cancer. 2003 Mar 1;97(5):1195-202.

PMID:
12599225
[PubMed - indexed for MEDLINE]
Free Article
8.

Epidermal growth factor receptor expression as prognostic marker in patients with anal carcinoma treated with concurrent chemoradiation therapy.

Fraunholz I, Rödel F, Kohler D, Diallo-Georgiopoulou M, Distel L, Falk S, Rödel C.

Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):901-7. doi: 10.1016/j.ijrobp.2013.03.039. Epub 2013 Jun 5.

PMID:
23755922
[PubMed - indexed for MEDLINE]
9.

Combined radiation and chemotherapy for epidermoid carcinoma of the anal canal.

Schneider IH, Grabenbauer GG, Reck T, Köckerling F, Sauer R, Gall FP.

Int J Colorectal Dis. 1992 Dec;7(4):192-6.

PMID:
1293239
[PubMed - indexed for MEDLINE]
10.

Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients.

Seo Y, Kinsella MT, Reynolds HL, Chipman G, Remick SC, Kinsella TJ.

Int J Radiat Oncol Biol Phys. 2009 Sep 1;75(1):143-9. doi: 10.1016/j.ijrobp.2008.10.046. Epub 2009 Feb 7.

PMID:
19203845
[PubMed - indexed for MEDLINE]
11.

Sphincter preservation with chemoradiation in anal canal carcinoma: abdominoperineal resection in selected cases?

Grabenbauer GG, Matzel KE, Schneider IH, Meyer M, Wittekind C, Matsche B, Hohenberger W, Sauer R.

Dis Colon Rectum. 1998 Apr;41(4):441-50.

PMID:
9559628
[PubMed - indexed for MEDLINE]
12.

Coordinated expression of desmoglein 1 and desmocollin 1 regulates intercellular adhesion.

Getsios S, Amargo EV, Dusek RL, Ishii K, Sheu L, Godsel LM, Green KJ.

Differentiation. 2004 Oct;72(8):419-33.

PMID:
15606501
[PubMed - indexed for MEDLINE]
13.

Radiochemotherapy in the conservative treatment of anal canal carcinoma: retrospective analysis of results and radiation dose effectiveness.

Ferrigno R, Nakamura RA, Dos Santos Novaes PE, Pellizzon AC, Maia MA, Fogarolli RC, Salvajoli JV, Filho WJ, Lopes A.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1136-42.

PMID:
15752894
[PubMed - indexed for MEDLINE]
14.

Molecular biomarkers correlate with disease-free survival in patients with anal canal carcinoma treated with chemoradiation.

Ajani JA, Wang X, Izzo JG, Crane CH, Eng C, Skibber JM, Das P, Rashid A.

Dig Dis Sci. 2010 Apr;55(4):1098-105. doi: 10.1007/s10620-009-0812-6. Epub 2009 Apr 28.

PMID:
19399614
[PubMed - indexed for MEDLINE]
15.

P-cadherin expression predicts clinical outcome in oral squamous cell carcinomas.

Lo Muzio L, Pannone G, Mignogna MD, Staibano S, Mariggiò MA, Rubini C, Procaccini M, Dolci M, Bufo P, De Rosa G, Piattelli A.

Histol Histopathol. 2004 Oct;19(4):1089-99.

PMID:
15375751
[PubMed - indexed for MEDLINE]
17.

[Epidermoid carcinomas of the anal canal treated with definitive radiation therapy in a series of 305 patients].

Deniaud-Alexandre E, Touboul E, Tiret E, Sezeur A, Houry S, Gallot D, Parc R, Huang R, Qu SH, Pène F, Schlienger M.

Cancer Radiother. 2003 Aug;7(4):237-53. French.

PMID:
12914857
[PubMed - indexed for MEDLINE]
18.

Assembly of desmosomal cadherins into desmosomes is isoform dependent.

Ishii K, Norvell SM, Bannon LJ, Amargo EV, Pascoe LT, Green KJ.

J Invest Dermatol. 2001 Jul;117(1):26-35.

PMID:
11442746
[PubMed - indexed for MEDLINE]
Free Article
19.

Impact of overall treatment time on local control of anal cancer treated with radiochemotherapy.

Graf R, Wust P, Hildebrandt B, Gögler H, Ullrich R, Herrmann R, Riess H, Felix R.

Oncology. 2003;65(1):14-22.

PMID:
12837978
[PubMed - indexed for MEDLINE]
20.

Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes.

Klas JV, Rothenberger DA, Wong WD, Madoff RD.

Cancer. 1999 Apr 15;85(8):1686-93. Review.

PMID:
10223561
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk